717 / 879
7
Further reading
• Global harmonization of quality assurance naming conventions in radiation therapy clinical trials.Melidis C,
Bosch WR, Izewska J, Fidarova E, Zubizarreta E, Ulin K, Ishikura S, Followill D, Galvin J, Haworth A, Besuijen D,
Clark CH, Miles E, Aird E, Weber DC, Hurkmans CW, Verellen D. Int J Radiat Oncol Biol Phys. 2014 Dec
1;90(5):1242-9
• Institutional Patient-specific IMRT QA Does Not Predict Unacceptable Plan Delivery.Kry SF, Molineu A, Kerns
JR, Faught AM, Huang JY, Pulliam KB, Tonigan J, Alvarez P, Stingo F, Followill DS. Int J Radiat Oncol Biol Phys.
2014 Dec 1;90(5):1195-201
• Quality assurance standards drive improvements in the profile of radiation therapy departments participating in trials of the EORTC Radiation Oncology Group. Grant W, Hurkmans CW, Poortmans PM, Maingon P, Monti AF,van Os MJ, Weber DC. Radiother Oncol. 2014 Sep;112(3):376-80
• IMRT credentialing for prospective trials using institutional virtual phantoms: results of a joint European Organization for the Research and Treatment of Cancer and Radiological Physics Center project. Weber DC, Vallet
V, Molineu A, Melidis C, Teglas V, Naudy S, Moeckli R, Followill DS, Hurkmans CW. Radiat Oncol. 2014 May
29;9:123
• Outcome impact and cost-effectiveness of quality assurance for radiotherapy planned for the EORTC 22071-24071 prospective study for head and neck cancer. Weber DC, Hurkmans CW, Melidis C, Budach W, Langendijk JH,Peters LJ, Grégoire V, Maingon P, Combescure C. Radiother Oncol. 2014 Jun;111(3):393-9
• Radiation therapy quality assurance in clinical trials--Global Harmonisation Group.Melidis C, Bosch WR, Izewska
J, Fidarova E, Zubizarreta E, Ishikura S, Followill D, Galvin J, Xiao Y, Ebert MA, Kron T, Clark CH, Miles EA, Aird
EG, Weber DC, Ulin K, Verellen D, Hurkmans CW. Radiother Oncol. 2014 Jun;111(3):327-9
• QA makes a clinical trial stronger: evidence-based medicine in radiation therapy.Weber DC, Tomsej M, Melidis C,
Hurkmans CW. Radiother Oncol. 2012 Oct;105(1):4-8